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AbstrACt
Objectives To generate system insights on patient and 
provider levers and strategies that must be activated to 
improve hospital-based smoking cessation treatment.
Design Mixed methods study including a series of in-
depth group model building sessions, which informed 
the design of an online survey completed by healthcare 
providers and a structured interview protocol administered 
at the bedside to patients who smoke.
setting Large, tertiary care hospital in the Midwestern 
United States.
Participants  Group model building: 28 healthcare 
providers and 22 previously-hospitalised patients; Online 
survey: 308 healthcare providers; Bedside interviews: 205 
hospitalised patients.
Primary and secondary outcome measures Hypothesis-
generating, participatory qualitative methods informed the 
examination of the following quantitative outcomes: patient 
interest versus provider perception of patient interest in 
smoking cessation and treatment; patient-reported receipt 
versus provider-reported offering of inpatient smoking 
cessation interventions; and priority ratings of importance 
and feasibility of strategies to improve treatment.
results  System insights included patients frequently 
leaving the floor to smoke, which created major workflow 
disruption. Leverage points included interventions to 
reduce withdrawal symptoms, and action ideas included 
nurse-driven protocols for timely administration of nicotine 
replacement therapy. Quantitative data corroborated 
system insights; for instance, 80% of providers reported 
that patients frequently leave the floor to smoke, leading 
to safety risks, missed assessments and inefficient use 
of staff time. Patients reported significantly lower rates of 
receiving any smoking cessation interventions, compared 
with provider reports (mean difference=17.4%–33.7%, 
p<0.001). Although 92% of providers cited patient interest 
as a key barrier, only 4% of patients indicated no interest 
in quitting or reducing smoking.
Conclusions Engaging hospital providers and patients in 
participatory approaches to develop an implementation 
strategy revealed discrepant perceptions of patient interest 
and frequency of hospital-based treatment for smoking. 
These findings spurred adoption of standardised point-
of-care treatment for cigarette smoking, which remains 
highly prevalent yet undertreated among hospitalised 
patients.
IntrODuCtIOn
Cigarette smoking remains the leading cause 
of preventable death worldwide.1–4 National 
efforts directed at reducing tobacco use have 
contributed to a decline in the proportion of 
combustible cigarette smokers.5 6 However, 
smoking prevalence among those entering 
hospital settings remains much higher than 
in the general population, as those with 
chronic conditions have higher prevalence 
of smoking.7 8 Hospital settings therefore 
present an opportune time to promote cessa-
tion.9 10 
Despite the existence of effective, Food 
and Drug Administration–approved medi-
cations for smoking cessation—including 
nicotine replacement therapy, varenicline 
and bupropion11–13—which can be combined 
with brief counselling for optimal success,14 
these treatments remain underutilised in 
inpatient settings.15–17 In our hospital, only 
18%–24% of patients who smoke received 
smoking cessation pharmacotherapy during 
hospitalisation from 2010 to 2016.8 Further, 
strengths and limitations
 ► Using a systems science lens, this study integrat-
ed multiple data sources to inform more systematic 
provision of smoking cessation treatment practices 
in hospital settings.
 ► This study featured a rigorous mixed methods ap-
proach whereby hypothesis-generating qualitative 
data informed the design of quantitative instruments 
and guided interpretation of resulting quantitative 
data.
 ► The use of participatory approaches to engage 
healthcare provider and patient stakeholders iden-
tified provider and patient levers to be activated in a 
robust implementation strategy.
 ► Despite having many similarities to other health-
care systems in the nation, study findings are based 
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these medications were often prescribed inconsistently 
between admitting services and subdemographic groups 
in our hospital. For instance, African Americans were 
35% less likely than European Americans to receive 
smoking cessation pharmacotherapies during their 
hospital stay, which highlights concerning inequalities 
in hospital prescribing practices.8 Similar patterns were 
found in a study of smoking cessation pharmacotherapy 
rates among smokers hospitalised for an acute cardiac 
condition across 282 US hospitals; the median treatment 
rate was 22.3% and even lower among minority racial/
ethnic groups.17 Treatment rates across these hospitals 
were also highly variable, suggesting that hospitals may 
be using, with varying levels of success, different strate-
gies to implement inpatient smoking cessation treatment 
programmes.
These treatment gaps and disparities indicate subop-
timal care, as inpatient smoking cessation pharmaco-
therapy in combination with postdischarge treatment has 
been shown in meta-analyses to improve quit rates and 
is now considered the standard of care by Joint Commis-
sion.10 15 Nevertheless, these treatment gaps and dispari-
ties signal that the implementation of smoking cessation 
treatment approaches remains a formidable challenge in 
hospital settings. Currently, it is not clear which patient 
and provider levers and strategies must be activated to 
improve smoking cessation treatment in hospital settings. 
Additionally, there is inadequate guidance on the best 
system-level implementation strategies to use to improve 
treatment delivery for hospitalised patients who smoke. 
The healthcare system requires pragmatic evidence to 
increase the likelihood that other hospitals use strategies 
that were robustly supported by rigorous yet relevant data 
and decrease the likelihood that hospitals use strategies 
without robust support. However, obtaining pragmatic, 
rigorous and relevant data may require novel uses of 
methods including more participatory, stakeholder-en-
gaged approaches that integrate diverse types of data to 
gain a better understanding of the system-level gaps in 
care, high-leverage target areas to focus change efforts 
and specific strategies that can improve the treatment 
of patients who smoke. This study uses a systems science 
lens that integrates multiple data sources to inform more 
systematic provision of smoking cessation treatment prac-
tices in hospital settings, thereby using a novel approach 
to address a thorny problem that has challenged health-
care systems for decades.
study purpose
The goal of the study was to understand determinants of 
the treatment gap in hospitalised patients who smoke and 
inform the development of stakeholder-supported strate-
gies for improving smoking cessation treatment delivery 
in the inpatient setting. Building on our robust, validated 
electronic health record data demonstrating subop-
timal smoking cessation pharmacotherapy prescription 
practices,8 this study integrated multiple data sources to 
inform more systematic provision of smoking cessation 
treatment practices in hospital settings. To our knowl-
edge, this is the only study to engage with hospital patients 
and providers in a participatory process to identify the 
underlying system structure producing the treatment 
gap, collateral effects of this gap (eg, impacts on provider 
workflow), optimal leverage points and actionable strate-
gies to yield consistent delivery of smoking cessation care 
in hospital settings.18–21
MethODs
This mixed methods study integrated qualitative and 
quantitative data sources including in-depth group 
model building sessions with healthcare providers and 
patients,21 22 followed by an online survey with healthcare 
providers and bedside interviews with patients.
Phase I: group model building with healthcare providers and 
patients (qualitative work)
Participants and procedures
Participants were recruited from Barnes-Jewish Hospital 
(BJH), a large tertiary care hospital. We engaged two 
participant populations1: BJH employees including 
physicians, nurses and support staff with patient contact 
and2patients who had recently received care at BJH and 
who self-identified as current smokers at the time of 
their most recent hospital admission. To recruit health-
care providers, we requested programme directors and 
nursing supervisors of a diverse set of service lines—
including general surgery, internal medicine, neurology, 
oncology, orthopaedics, otolaryngology and psychi-
atry—to distribute recruitment materials to employees 
who may be eligible to participate. We excluded partici-
pants from the intensive care unit, emergency room and 
operating room due to lower relevance of the topic in 
these acute care settings. We also prioritised our active 
recruitment efforts within service lines likely to find the 
topic most relevant for their service delivery; therefore, 
some hospital services (eg, plastic surgery, urology) fell 
outside the scope of our recruitment efforts. To recruit 
patients who had been previously hospitalised at BJH, 
we distributed a recruitment email through a research 
participant registry to potentially eligible individuals who 
smoke, posted a Facebook advertisement on the registry 
fan page listing, and hung printed flyers in the hospital. 
Those interested in participating were screened using a 
standardised telephone script.
We engaged 50 stakeholders in five group model 
building sessions comprised of patients (two sessions, 
n=22); nurses, social workers and case managers (one 
session, n=14); nurse practitioners, hospitalists and phar-
macists (one session, n=6); and resident physicians (one 
session, n=8). Using a standard process for synthesising the 
models,22–24 we then invited all participants in the initial 
sessions to reconvene for a model review that functioned 
to present a preliminary synthesis model for critique and 
refinement of the stakeholder-generated model (one 
session, n=16). Patients and providers stemmed from a 
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wide variety of hospital service lines, including cardiology, 
general surgery, internal medicine, neurology, obstetrics, 
oncology, orthopaedics, otolaryngology and psychiatry. 
We received participation from each service line from 
which we recruited. Sessions were conducted between 
late October 2017 and early February 2018.
Planning, conduct and analysis of the series of sessions 
were led by a core modelling team, including the prin-
cipal investigator, BJH nursing partner and two experts 
in group model building and community-based system 
dynamics. Each group model building session utilised 
a facilitation team, which included the conveners/closers 
(principal investigator and nursing partner), primary 
modeller (lead expert in group model building), facilita-
tors (approximately two support experts in group model 
building) and note takers (approximately two additional 
team members). The group model building team used 
scripts23 or a pre-defined set of exercises and behaviours 
to provide a semistructured environment for1patient 
stakeholder groups to model a typical sequence of clinical 
encounters that may or may not result in patients being 
offered smoking cessation treatment and2 healthcare 
provider stakeholder groups to model a typical sequence 
of clinical decision points with regard to ordering and 
administering smoking cessation treatment and offering 
counselling in the hospital. Patient participants were then 
asked to identify factors that determine the likelihood of 
being offered and receiving smoking cessation treatment. 
Similarly, healthcare provider participants were asked to 
identify factors that determine the likelihood of offering 
smoking cessation pharmacotherapy and counselling, the 
likelihood of patients accepting pharmacotherapy and 
counselling, sources of decision-making and workflow 
barriers. All participants were then asked to prioritise the 
identified factors and position them as intervening vari-
ables within the modelled sequence of events.
Mixed methods analytic approach
We used an exploratory sequential design in which qual-
itative data from the group model building sessions 
informed the design of the quantitative online survey and 
patient bedside interviews.25 The qualitative data were 
hypothesis generating to further guide the development 
of the quantitative measures and interpretation of the 
resulting quantitative data.
Phase II: online survey with healthcare providers (quantitative 
and qualitative)
Participants and procedures
We recruited healthcare providers to complete an anony-
mous 10-min online survey by emailing a cover letter and 
survey link to administrative contact persons, programme 
directors and nursing staff who then distributed the email 
through their networks. Participants of the online survey 
included 308 providers (112 physicians, 196 nurses) 
from BJH with direct inpatient contact. Participants were 
located across a wide range of service lines, with internal 
medicine (46%) and general surgery (22%) being the 
most highly represented. As in phase I, we excluded 
participants from the intensive care unit, emergency 
room and operating room due to lower relevance of the 
topic in these acute care settings. Of physicians, 79% were 
resident physicians, and 21% were hospitalists. Of nurses, 
47% were staff nurses, 30% nurse practitioners and 23% 
other types of nurses. Nurses and physicians were asked 
via quantitative assessments about their current smoking 
cessation treatment practices—namely the use of the 
‘5As’: Ask about tobacco use, Advise to quit smoking, 
Assess readiness for quit attempt, Assist with medication 
and counselling options and Arrange follow-up contact or 
referral,26–28 barriers to using these practices, perceived 
patient interest in various smoking cessation resources 
during an inpatient stay, perceived importance and feasi-
bility of various potential strategies to improve practices 
and the frequency of workflow and safety issues related 
to hospitalised patient smoking. Qualitative data were 
obtained through an open-ended prompt to share ‘final 
thoughts or comments on the topic of smoking cessation 
treatment at BJH’. The online survey remained open 
from late February 2018 to late March 2018.
Phase III: bedside interviews with patients (quantitative)
Participants and procedures
We recruited hospitalised patients to complete a struc-
tured 5-min interview at the bedside. Whereas patients 
in phase I were recruited subsequent to their hospitalisa-
tion as necessary for convening the group model building 
sessions, patients recruited in phase III for the brief indi-
vidualised interviews were still hospitalised yet nearing 
discharge. This facilitated accurate recall of events while 
minimising the risk of missing patients who had recently 
been discharged or delaying patients’ ability to exit the 
hospital once discharged. We obtained reports daily 
during the month of May 2018 from the hospital electronic 
health record to identify potentially eligible patients and 
conducted all interviews during this time period. Partic-
ipants of the bedside interviews included 205 inpatients 
who were categorised by electronic health record as 
current smokers and nearing hospital discharge. Partici-
pants were more often male (56%) and Caucasian (59%), 
with a median age of 54 years (M=50.25; SD=15.22). These 
demographics appeared to be very similar to those of the 
larger population of BJH patients across the hospital who 
were current smokers during this time frame (May 2018). 
On average, participants smoked 14.0 cigarettes per day 
and had stayed in the hospital for 4.5 days within a variety 
of admitting services, including internal medicine (38%), 
surgery (23%), oncology (13%), cardiology (12%), 
neurology (7%) and orthopaedics (5%). Based on an 
existing questionnaire to compare patient and provider 
reports in a different context,26patients were asked about 
their smoking behaviours (ie, verification of current 
smoker status prior to hospital admission, cigarettes per 
day and frequency of leaving the floor to smoke); ever 
and current e-cigarette use; smoking cessation care they 
had received during their current inpatient stay (ie, 
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receipt of the 5As: ask, advise, assess, assist and arrange); 
interest in quitting smoking now, quitting smoking later, 
smoking less, and methods to quit smoking (eg, medica-
tions); number of past-year quit attempts; and the impor-
tance of various potential strategies to improve practices 
(eg, offering medication to every patient who smokes).
Statistical analysis approach
Data from the healthcare provider online surveys and 
patient bedside interviews were first analysed descriptively 
via frequencies and means. Patient-reported receipt of 
5As smoking cessation practices was examined in relation 
to provider reports using summary independent-sample 
t-test analyses. Multiple linear analyses were conducted 
to determine associations between medication receipt 
and the likelihood and frequency of leaving the floor to 
smoke, controlling for cigarettes per day and length of 
stay. Missing data across variables were minimal (<2% for 
healthcare providers and <3% for patients) and handled 
via pairwise deletion.
Patient and public involvement
During participant recruitment, patients were able to 
identify other potentially eligible individuals who smoke 
to be screened for enrollment. Through the participatory 
group model building sessions, patients generated key 
system insights that informed the research questions and 
outcome measures to be assessed in the subsequent online 
survey for healthcare providers and bedside interview 
protocol for patients. For instance, patients expressed 
significant frustration regarding being asked repeatedly 
about their smoking behaviours without being offered 
any help to quit smoking during their hospital stay. As a 
result, the research team prioritised questions in the quan-
titative instruments to assess the frequency of patient- and 
provider-reported delivery of smoking cessation interven-
tions, as well as patient and provider reports of patient 
interest in receiving smoking cessation treatment while 
hospitalised. This research reflects a key step in devel-
oping a system-level intervention; therefore, patient input 
is contributory to ongoing research and practice improve-
ments. We plan to disseminate results of this study to 
patients and other participants by presenting findings at 
local symposia and conferences that are well attended by 
patients, patient advocates, healthcare providers and the 
broader community. We will also present these findings 
during healthcare provider training workshops, whereby 
patients benefit through improved quality of smoking 
cessation care in the hospital.
results
Phase I: group model building
System insights—‘what factors determine the likelihood that 
patient smoking will be treated?’
Based on factors prioritised by participants during group 
model building, the research team generated a multi-
level (ie, individual, hospital, community and policy) 
understanding, referred to as system insights, that char-
acterised the observed undertreatment of patients who 
smoke. Online supplementary file 1 illustrates the inten-
tionally oversimplified backbone structure to which 
participants were responding and building on with 
content and context. These insights included provider 
reports of patients frequently leaving the floor to smoke, 
which created major workflow problems and enhanced 
provider receptivity to solutions framed to address ‘nico-
tine withdrawal’ rather than ‘cessation’. A commonly 
reported scenario involved untreated hospital patients 
going outside to smoke, leading to missed assessments 
or procedures, which then prompted nurses to priori-
tise smoking cessation medications to prevent further 
workflow disruptions. Providers also reported a lack of 
awareness of resources and enthusiasm balanced with 
concerns about time, while patients reported infrequent 
receipt of smoking cessation support and preferences for 
non-judgemental communication (see table 1).
Potential leverage points—‘what targets could lead to major 
system-level improvements?’
With these system insights providing the appropriate 
frame, the modelling group then identified potential 
leverage points to target for action. Leverage points 
refer to places within a complex system in which a small 
change can produce large changes in the overall system 
behaviour.29 Potential leverage points to address provid-
er-reported insights included interventions framed as 
solutions to reduce nicotine withdrawal and subsequent 
workflow problems, education and decision support and 
a standardised approach to smoking cessation treatment. 
Potential leverage points to address patient-reported 
insights included transparency of patient interest and use 
of treatment and patient-provider rapport through more 
supportive cessation messaging (see table 1).
Action ideas—‘which specific strategies appear both highly 
important and feasible?’
Finally, stakeholders used these potential leverage points 
as the frame for nominating potential concrete solutions 
and then prioritising them on perceived importance 
and feasibility in the hospital setting. Providers gener-
ated action ideas to address their own provider-reported 
insights and leverage points, including implementing 
nurse-driven protocols for timely administration of inpa-
tient nicotine replacement therapy, using an assortment 
of provider training approaches, designing electronic 
health records to support point-of-care decisions and 
offering point-of-care advice, medication and links to 
outpatient counselling. Patients generated action ideas to 
address their own patient-reported insights and leverage 
points, including creating provider feedback systems, 
developing cessation plans for discharge, offering help 
to every patient who smokes and revamping hospital 
signage for more positive messaging (see table 1). These 
system insights, potential leverage points and action 
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ideas were then examined more closely in the subse-
quent online survey with providers and bedside inter-
views with patients.
Phase II: healthcare provider online survey
Qualitative data
Open-ended responses from the provider sample were 
useful in expanding further on the group model building 
data. Key representative quotes are included in table 1 to 
reinforce themes from the group model building sessions.
Quantitative data
Rates of smoking cessation practice varied substantially 
across the 5As, with the majority of providers indicating 
regular completion of Ask (88%), Advise (79%), Assess 
(62%) and Assist (63%), with lower rates for Arrange 
(24%). Additionally, 64% of providers reported that they 
often-to-always encourage the use of medication (eg, nico-
tine replacement therapy and varenicline) with patients 
for smoking cessation.
The most commonly cited barriers to providing treat-
ment were patient lack of interest (92%) and compliance 
(92%), followed by lack of awareness of existing commu-
nity resources for patient referral (72%) and lack of time 
(71%).
Approximately 80% of providers reported that patients 
often or very often leave the floor to smoke, and this 
frequently leads to patients posing a safety risk (75% 
reported often or very often), assessments being missed 
(51% reported often or very often) and staff time used to 
escort patients off the floor (42% reported often or very 
often).
The strategies rated as most important for improving 
smoking cessation treatment at the hospital were also the 
ones rated as most feasible. These top strategies included 
asking every patient who smokes if they want help (86% 
endorsed as very or extremely important; 77% endorsed 
as very or extremely feasible), offering brief advice to 
every patient who smokes (65% endorsed as very or 
extremely important; 56% endorsed as very or extremely 
feasible) and offering medication to every patient who 
smokes (62% endorsed as very or extremely important; 
52% endorsed as very or extremely feasible).
Phase III: patient bedside interviews
Table 2 highlights high levels of patient smoking cessation 
interest and attempts. In particular, nearly three-fourths 
(73%) were interested in quitting now, and nearly all 
(96%) were interested in quitting or smoking less. Most 
patients (59%) had tried quitting in the past year. Nearly 
two-thirds (65%) had ever used e-cigarettes, and 12% 
currently used them.
Regarding comparisons between patient and provider 
reports of the 5As, patients reported rates similar to 
providers on Ask (mean difference=−1.4%; p=0.653); 
however, they reported much lower rates of receiving 
Advise (mean difference=−27.5%; p<0.001), Assess 
(mean difference=−33.7%; p<0.001), Assist (mean 
difference=−19.2%; p<0.001) and Arrange (mean differ-
ence=−17.4%; p<0.001) steps (see figure 1), as well 
as being provided with medication to quit smoking 
during their inpatient stay (mean difference=−35.0%; 
P<0.001; see figure 2). Additionally, in contrast to 92% 
of providers citing patient interest as a key barrier to 
smoking cessation treatment, only 4% of patients indi-
cated no interest in quitting at some point or smoking 
less, and only 27% of patients indicated no interest in 
quitting now.
Nearly one-third (31%) of patients reported that they 
had left the floor to go smoke during their hospital stay, 
and nearly two-thirds of those who left did so multiple 
times per day. Overall, receipt of inpatient smoking cessa-
tion medication was not significantly associated with 
leaving the floor to smoke (p=0.331). However, among 
patients who left, those who did not receive smoking 
cessation medications were more likely to report leaving 
multiple times per day than those who received medica-
tions, controlling for cigarettes per day and length of stay 
(OR=3.3, p=0.036).
Patients were well-aligned with providers regarding 
perceived importance of potential strategies to improve 
smoking cessation treatment in the hospital (see figure 3). 
The most highly rated strategies were to ask every patient 
who smokes if they want help (76% endorsed as very or 
extremely important), offer medication to every patient 
who smokes (67%) and offer brief advice to every patient 
who smokes (58%).




Interested in quitting now 146/200 (73)
Interested in quitting now or later 188/202 (93)
Interested in quitting now or later or smoking 
less
193/202 (96)
Past year quit attempt 118/201 (59)
Ever used e-cigarettes 131/202 (65)
Currently used e-cigarettes 25/202 (12)
Figure 1 Providers and patients report discrepant rates of 
inpatient smoking cessation treatment.
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DIsCussIOn
Extensive research has examined the hospital as a prime 
setting to engage patients in smoking cessation treat-
ment, as well as effective treatment approaches to employ 
in hospital settings,9–14 yet persistent treatment gaps 
signal formidable implementation challenges.15–17 This 
study uniquely employed a systems science lens to frame 
the implementation challenges and opportunities using 
a rigorous mixed methods approach to generate system 
insights, potential leverage points and specific strategies 
to improve the treatment of hospitalised patients who 
smoke. Key contributions of this research include (1) 
detailing an underutilised participatory, stakeholder-en-
gaged process to yield hypothesis-generating qualitative 
data that informed the design and interpretation of quan-
titative data and (2) a robust set of provider and patient 
levers to be activated in a multicomponent implementa-
tion strategy in future research.
Healthcare providers reported that patient smoking 
during a hospitalisation created significant workflow 
issues for hospital staff. Despite low current rates of 
smoking cessation pharmacotherapy prescribing, we 
found high patient demand to quit smoking. Provider-re-
ported barriers centred on a perceived lack of patient 
interest, time, and awareness of existing resources; these 
barriers reflect aspects of motivation, opportunity, and 
capability, which have been identified as key determi-
nants of behavioural change and fruitful targets for inter-
vention.30 31
Despite the wealth of research on inpatient smoking 
and hospital-based cessation treatment, far fewer studies 
have focused on potential collateral effects of inpatient 
smoking and treatment gaps, such as impeded provider 
workflow characterised by missed assessments and proce-
dures, misuse of staff time and potential safety concerns, 
as found in the current study. Importantly, providers were 
much more receptive to and compelled by approaches to 
prevent the chain of events involving nicotine withdrawal, 
patients leaving the floor to smoke, and workflow prob-
lems, as opposed to approaches framed as promoting 
smoking cessation among hospitalised patients. This 
finding has significant implications for approaches to 
engaging hospital providers in the treatment of inpa-
tients who smoke.
Whereas previous research found that nearly one in five 
smokers admitted to a hospital smoked cigarettes during 
their hospital stay,32 the rate was nearly one in three among 
smokers sampled in our hospital setting. Interestingly, 
based on patient reports, receipt of nicotine replacement 
therapy was not associated with whether or not patients 
left the floor to smoke at least once; however, patients 
receiving nicotine replacement therapy were more likely 
to have only left the floor to smoke once. Therefore, it is 
possible that patients may have been receiving nicotine 
replacement therapy in response to leaving the floor to 
Figure 2 Despite high interest, fewer patients receive pharmacologic cessation treatment than indicated by providers.
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smoke (eg, missing patient prompts the provider to offer 
treatment for nicotine withdrawal), thereby reducing the 
likelihood that patients subsequently left due to nicotine 
withdrawal during their hospital stay. This hypothesis 
would require further testing, including an establishment 
of temporal precedence to demonstrate the risk of patient 
smoking before and after receiving nicotine replacement 
therapy in the hospital setting.
Regarding points of (mis)alignment between patient 
and provider perceptions, both groups reported high 
rates of asking patients whether or not they smoke. 
However, patients reported much lower rates of receiving 
any smoking cessation support and much higher levels 
of interest in cessation, compared with provider reports. 
This finding replicates recent research in mental health 
settings26 and was corroborated by qualitative data, which 
characterised the patient perception that providers 
frequently ask about smoking behaviours, yet no actions 
result from these inquiries. Improved alignment of 
perceptions could benefit patient-provider rapport and 
increase acceptance of smoking cessation treatments 
when offered—opportunities which were all raised by 
patients during group model building discussions.
Finally, patients and providers agreed that the most 
important strategies were to ask every patient who smokes 
if they want help and offer medication and brief advice 
to every patient who smokes. Providers also found these 
to be the most feasible potential strategies, despite the 
patient reports that these were not frequently occurring. 
While seen as feasible, providers may perceive the need 
for a hospital-wide programme that expects, supports 
and reinforces the practice of offering treatment to 
every patient who smokes. As noted in a recent system-
atic review,31standardised implementation of this type of 
opt-out programme that leverages lighter-touch point-
of-care support may in fact ease provider burden and 
workflow. In addition, the alignment between patients 
and providers in ratings of importance and feasibility 
give additional credence to the viability of implementing 
these proposed strategies in hospital settings.
Limitations of this study include being based in one 
large tertiary care hospital system in the Midwestern 
United States. However, there are indications that this 
hospital system is largely representative of other systems 
in the nation. For instance, researchers recently found 
smoking cessation medication rates of 22.3% across 282 
US hospitals,17 nearly identical to our rate of approxi-
mately 22% across years 2010–2016. In addition, patient 
recruitment for the group model building sessions was 
limited to a research participant registry; as a pool of 
patients who are willing to be contacted about research 
studies, participants from this registry may differ some-
what from patients at-large. For the online survey, the 
link was distributed by the primary contacts of hospital 
divisions, and it was not possible to determine how 
many healthcare providers received the opportunity to 
complete the survey. As a result, we were unable to ascer-
tain response rate and therefore cannot rule out the 
possibility of sampling bias. Finally, patients and providers 
from psychiatric services may have different perceptions 
about smoking cessation treatment compared with other 
patient and provider groups. However, only two partici-
pants from psychiatry were included in the exploratory 
phase of our study (phase I), and no participants from 
psychiatry were included in phases II and III in which we 
compared provider and patient reports of treatment (ie, 
5As) offering and receipt.
COnClusIOn
Our findings have led our hospital to adopt standardised, 
lighter-touch yet higher-reach approaches to smoking 
cessation treatment, supported by provider feedback and 
simplified decision support and enabled through the 
electronic health record system.9 20 33 34 Prior reviews and 
studies frequently highlight the importance of directly 
targeting hospital systems, including integrating key 
performance indicators into electronic health records, to 
improve the delivery of hospital smoking cessation care 
and the sustainability of those improvements.35 Despite 
the local system changes, the primary contribution of 
these findings is in providing generalisable evidence to 
help other researchers, providers and hospital adminis-
trators to prioritise the use of implementation strategies 
that were robustly supported across each phase of our 
mixed methods study. The potential leverage points we 
identified point to the following specific strategies:
1. Create a standardised and coordinated approach to smoking 
cessation treatment: provide point-of-care brief advice, 
opt-out medication and discharge links to community 
resources, including quit-line counselling, to every pa-
tient who smokes.
2. Foster provider engagement by identifying and framing in-
terventions as solutions to reduce nicotine withdrawal and 
subsequent workflow problems related to patients leaving the 
floor to smoke: use nurse-driven protocols to ensure that 
readily accessible nicotine replacement therapy can be 
provided to inpatients with little delay.
3. Offer positive, supportive and non-judgemental messaging to 
patients: revamp hospital signage to incorporate pos-
itive messaging on smoking cessation and focus on 
boosting confidence and motivation to quit in patients 
who smoke36.
4. Improve awareness, knowledge, self-efficacy and attitudes: 
use continuing medical education, roving in-services 
and quick reference tools to train providers on existing 
and effective treatments and how to implement them.
5. Increase transparency regarding patient interest in and use of 
treatment: give providers feedback on ongoing perfor-
mance and aggregate rates of patient-reported readi-
ness to quit and engagement with quit-line counselling 
to foster awareness and accountability.
Engaging hospital stakeholders through a process of 
self-identification of approaches to addressable problems 
presents opportunities to fit high-leverage challenges with 
sustainable, contextually appropriate solutions. Findings 
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from this study inform engagement with healthcare 
provider and patient stakeholders in the development 
and implementation of proposed strategies to facilitate 
consistent delivery of smoking cessation treatment prac-
tices in the hospital setting.
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